If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAxis Bank 144a Regulatory News (AXBA)

Share Price Information for Axis Bank 144a (AXBA)

Share Price is delayed by 15 minutes
Get Live Data
40.9145    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $25.46b
AXBA Live PriceLast checked at - London Stock Exchange

Intraday Axis Bank 144a Share Chart

Cessation of Director

20 Dec 2021 07:00

RNS Number : 1125W
Axis Bank Limited
20 December 2021
 

AXIS/CO/CS/493/2021-22

 

December 18, 2021

Dear Sir(s),

 

SUB.: CESSATION OF TENURE OF STEPHEN PAGLIUCA, NON-EXECUTIVE (NOMINEE) DIRECTOR OF AXIS BANK LIMITED ("BANK").

 

REF.: REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015.

 

This is to inform you that Stephen Pagliuca has ceased to be the Non-Executive Director (Nominee of entities affiliated to Bain Capital) of the Bank, with effect from the close of business hours on Saturday, December 18, 2021, upon expiry of his tenure pursuant to the Investment Agreement between the Bank and BC Asia Investments VII Limited, Integral Investments South Asia IV and BC Asia Investments III Limited ("Investment Agreement"). Consequently, the tenure of Ashish Kotecha as an Alternate Director to the Original Director, Stephen Pagliuca has also expired with effect from the said date.

 

Further, kindly note that the Bank vide its letter no. AXIS/CO/CS/483/2021-22 dated December 14, 2021 has already informed the exchanges regarding the appointment of Ashish Kotecha as an Additional Non-Executive (Nominee of entities affiliated to Bain Capital) Director of the Bank with effect from Sunday, December 19, 2021, pursuant to the Amendment Agreement to Investment Agreement between the Bank and BC Asia Investments VII Limited, Integral Investments South Asia IV and BC Asia Investments III Limited.

 

On behalf of the Bank, we would like to acknowledge the contributions rendered by Stephen Pagliuca during his tenure as a Non-Executive Director and place on record our deep appreciation for his insights and suggestions at the meetings of the Board/Committees of the Bank.

 

You are requested to take note of above and arrange to bring it to the notice of all concerned.

 

Thanking You.

Yours Sincerely,

For Axis Bank Limited

 

 

 

Puneet Sharma

President & Chief Financial Officer

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFSVFSLTLIL
Date   Source Headline
14th Mar 20247:00 amRNSChanges in Senior Management
7th Mar 20249:29 amRNSAllotment of Non Convertible Debentures
1st Mar 20245:01 pmRNSIssuance of Non Convertible Debentures
27th Feb 20242:07 pmRNSAppointment of Executive Director
21st Feb 20241:25 pmRNSCredit Rating
14th Feb 202412:39 pmRNSAppointment of Additional Independent Director
24th Jan 202410:49 amRNSOutcome of Board Meeting - 24012024
23rd Jan 202412:01 pmRNSInvestor Presentation and Press Release
23rd Jan 202411:46 amRNSOutcome of Board Meeting
18th Jan 20242:15 pmRNSCessation
3rd Jan 20243:11 pmRNSBoard Meeting Intimation
1st Dec 20231:52 pmRNSPostal Ballot Results
22nd Nov 20232:22 pmRNSCredit Rating - ICRA
17th Nov 20237:00 amRNSDisclosure under Reg 30 of SEBI (LODR) Reg. 2015
26th Oct 202312:56 pmRNSAppointment of Whole Time Director
25th Oct 202312:40 pmRNSRelated Party Transaction
25th Oct 202312:18 pmRNSInvestor Presentation and Press Release
25th Oct 202312:02 pmRNSOutcome of Board Meeting 25102023
17th Oct 202310:00 amRNSCredit Rating
6th Oct 20231:25 pmRNSBoard Meeting Intimation 25102023
3rd Oct 20233:00 pmRNSCredit Rating
26th Sep 202312:46 pmRNSPostal Ballot Notice
13th Sep 202310:07 amRNSDisclosure under Reg 30 of SEBI (LODR) Reg. 2015
17th Aug 20234:46 pmRNSRBI Approval for appointment of Subrat Mohanty
9th Aug 20231:45 pmRNSDisclosure under Reg 30 of SEBI (LODR) Regulations
9th Aug 202312:36 pmRNSDisclosure Under Reg 30 of SEBI (LODR) Reg, 2015
1st Aug 20234:58 pmRNSResignation of Independent Director
27th Jul 20231:54 pmRNSOutcome of Board meeting
27th Jul 202310:47 amRNSAppointment
26th Jul 202312:50 pmRNSInvestor Presentation and Press Release
26th Jul 202312:44 pmRNSOutcome of Board Meeting 26072023
17th Jul 20235:23 pmRNSReclassification of Promoter
27th Jun 20234:12 pmRNSCredit Rating
26th Jun 202312:09 pmRNSNotice of Annual General Meeting and Annual Report
16th Jun 20231:53 pmRNSAppointment of Non-Executive (Part-time) Chairman
30th May 20233:44 pmRNSIntimation of Record date for Dividend
30th May 20233:30 pmRNSAppointment of Additional Independent Director
4th May 20231:49 pmRNSReclassification of Promoter
28th Apr 20233:39 pmRNSAmendment to Articles of Association
28th Apr 20233:25 pmRNSReclassification of Promoter
28th Apr 20233:20 pmRNSResults of Postal Ballot
28th Apr 202311:18 amRNSAppointment of Whole Time Director
27th Apr 202312:44 pmRNSBoard Meeting Outcome - Dividend and Fund Raising
24th Apr 20237:00 amRNSDisclosure under Reg 30 of SEBI (LODR) Reg. 2015
29th Mar 20232:49 pmRNSPostal Ballot Notice
27th Mar 20233:47 pmRNSDisclosure under Reg. 30 of SEBI (LODR) Reg. 2015
14th Mar 20231:12 pmRNSRating Action by CRISIL RATINGS LIMITED
13th Mar 20231:56 pmRNSCredit Rating
23rd Feb 20233:17 pmRNSUpdate on acquisition of business undertakings
10th Feb 20231:27 pmRNSCessation of Independent Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.